New Jersey S3904 prohibits procurement of opioid antidotes from entities that settled claims for contributing to the opioid epidemic.
New Jersey S3904 prohibits the procurement of opioid antidotes from entities that have settled with state governments over legal claims related to actions contributing to the opioid epidemic. This includes affiliates or subsidiaries of such entities. However, entities that agreed to provide opioid antidotes in settlements before September 1, 2024, can continue to supply them until their settlement obligations are fulfilled.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.